XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Mar. 31, 2021
Mar. 31, 2020
Income Statement [Abstract]        
Product Revenue $ 18,240   $ 89,714  
Cost of product revenue 39,363   148,494  
Product gross profit (loss) (21,123)   (58,780)  
Collaborations revenue 20,113   42,387  
Operating expenses:        
General and administrative 1,313,252 $ 1,035,256 2,507,112 $ 2,347,422
Research and development 1,081,429 342,102 2,015,587 843,921
Total operating expenses 2,394,681 1,377,358 4,522,699 3,191,343
Loss from operations (2,395,691) (1,377,358) (4,539,092) (3,191,343)
Interest expense     (3,053) (2,697,507)
Net valuation change of instruments measured at fair value   31,716 1,974 (93,858)
Other income 1,775   186,775  
Loss before income taxes (2,393,916) (1,345,642) (4,353,396) (5,982,708)
Provision for income taxes
Net loss $ (2,393,916) $ (1,345,642) $ (4,353,396) $ (5,982,708)
Net loss per share:        
Basic and diluted (in Dollars per share) $ (0.21) $ (0.29) $ (0.46) $ (1.30)
Number of shares used in per share calculations:        
Basic and diluted (in Shares) 11,238,084 4,634,842 9,419,599 4,593,534